Meanwhile, the rapid emergence of mRNA based vaccines, with a significant number of trials initiated in just the last five years, highlights a paradigm shift in the field and shows a strong trend towards personalized strategies within the mRNA platform, representing 57 % of such studies.
← all excerpts
Therapeutic vaccines targeting solid tumors: A series of clinical trial analysis over the past decade.
1
—
—